Member Info for johnlaycock

Thanks Jimi. The pilot results are in fact higher than 20% in terms of patients who can't tolerate Clopidogrel. 29% lab tests and 31% pct. So all good.

With CE IVD and resulting international orders and other imminent pipeline news, it won't be necessary for any sort of consolidation.

- conclusion of pilot stroke test with updated NICE guidance due shortly afterwards

- CE IVD confirmation (next Friday is 4 weeks since the last update)

- MT-RNR1 update on installation of 5 new sites

.....another week closer to good news!

It also shows they think CE IVD is in the bag.

Thanks Jimi. Very reassuring to see they are recruiting for such a role....shows they must have global sales in the pipeline if they are recruiting for an installation position.

If a PE or anyone is building a stake under Aim rules, a TR1 form would need to be issued via a RNS. Yet another false rumour!

Such rubbish and scaremongering on this board today which ruins any attempt to have a decent debate about the company's future prospects and fantastic tests. For instance there was a post today stirring about delisting as 75% of the shares were out of the public hands. Why do people make such rubbish up?

Yes nominal sp is 1.5p so they can't raise lower than that and to dispel another myth, you can't delist from AIM unless you have 75% of shareholder agreement. Given turkeys dont vote for Christmas, they wouldn't be able to delist I suspect.

Yup panic sell of 114 shares to raise £1.66. Clearly a very astute investor.

Great RNS this morning but I think a big clue on the CYP2C19 pilot study from Prof Bill Newman in this mornings RNS...' We're already seeing the impact of rapid genetic testing for patients who had had a stroke or TIA, with our colleagues in centres around the country telling us they need results quickly to inform their practice and avoid delays to discharge'.

Sounds like the Genedrive PCT is the future!

Anyone that is 'disappointed ' about the RNS this morning hasn't a clue about its significance. We are now trialling in a new huge (cardiovascular) area.

But a hugely significant development. Great news.

Https://www.linkedin.com/posts/ginomiele_great-trip-to-the-uae-as-we-continue-to-raise-activity-7327276419888148480-YXrk?utm_source=share&utm_medium=member_android&rcm=ACoAAAAMhbsB_NgSe9dupPlFVCvI337zRJ75xs8

Https://www.linkedin.com/posts/genedrive-plc_gdr-stroke-clopidogrel-activity-7326887981082898432-CgO8?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAAAMhbsB_NgSe9dupPlFVCvI337zRJ75xs8&utm_campaign=copy_link

Https://events.teams.microsoft.com/event/801a9d64-d3b0-4b18-9834-93590da6ccf3@bd9ab103-f8aa-4ba2-bcf4-02260ae159e4

https://www.linkedin.com/posts/dr-mark-j-hudson-pea****-exroid_taking-clopidogrel-your-genes-could-be-activity-7326167212979798016-4ggu?utm_source=share&utm_medium=member_desktop&rcm=acoaaaamhbsb_ngse9dupplfvcvi337zrj75xs8

Website looks to have more info on and has been updated.

Interesting article Lionel. I wonder if anyone is considering making an approach to the company or is it too early in the commercialisation runway?

Thanks Jimi. Any idea when the findings and recommendations of the pilot study will be published?